Cardlytics, Inc. (NASDAQ:CDLX) Shares Acquired by RBF Capital LLC

RBF Capital LLC increased its holdings in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 64.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 803,763 shares of the company's stock after buying an additional 315,635 shares during the quarter. RBF Capital LLC owned about 1.58% of Cardlytics worth $2,982,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Mirabella Financial Services LLP bought a new position in shares of Cardlytics in the fourth quarter worth $4,285,000. Rangeley Capital LLC acquired a new position in Cardlytics during the 4th quarter valued at about $1,187,000. Natixis acquired a new position in Cardlytics during the 4th quarter valued at about $462,000. Geode Capital Management LLC raised its position in shares of Cardlytics by 7.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company's stock worth $3,371,000 after buying an additional 73,484 shares in the last quarter. Finally, XTX Topco Ltd acquired a new stake in shares of Cardlytics in the 4th quarter worth approximately $157,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on CDLX shares. Evercore ISI dropped their target price on Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a report on Thursday, March 13th. Needham & Company LLC restated a "hold" rating on shares of Cardlytics in a report on Thursday, March 13th. Finally, Lake Street Capital lowered their target price on Cardlytics from $5.00 to $3.00 and set a "hold" rating on the stock in a report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has an average rating of "Hold" and a consensus price target of $6.42.

Insider Activity at Cardlytics

In other Cardlytics news, CFO Alexis Desieno sold 24,778 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at $479,223.20. This trade represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the transaction, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. This trade represents a 10.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 90,475 shares of company stock worth $314,216 in the last quarter. 4.40% of the stock is owned by company insiders.

Cardlytics Stock Performance

Shares of NASDAQ CDLX opened at $1.54 on Wednesday. The stock's fifty day simple moving average is $2.11 and its 200 day simple moving average is $3.14. The stock has a market capitalization of $80.21 million, a price-to-earnings ratio of -0.25 and a beta of 1.39. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a 52-week low of $1.22 and a 52-week high of $15.89.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.